NEW YORK (GenomeWeb) – Veracyte announced today that Medicare contractor Palmetto GBA has issued a draft local coverage determination (LCD) for the company's Percepta Bronchial Genomic Classifier.
"As anticipated, we are moving quickly toward securing draft Percepta LCDs from all four [Molecular Diagnostic Services] program participants," Veracyte President and CEO Bonnie Anderson said in a statement.